{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:11:20Z","timestamp":1768036280298,"version":"3.49.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Great progress has been made in understanding the genetic and molecular basis of pheochromocytoma and paragangliomas (PPGLs). This review highlights the new standards in the diagnosis and management of pediatric PPGLs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The vast majority of pediatric PPGLs have an associated germline mutation, making genetic studies imperative in the work up of these tumors. Somatostatin receptor-based imaging modalities such as <jats:sup>68<\/jats:sup>Ga-DOTATATE and <jats:sup>64<\/jats:sup>Cu-DOTATATE are shown to have the greatest sensitivity in pediatric PPGLs. Peptide receptor radionuclide therapies (PRRTs) such as <jats:sup>177<\/jats:sup>Lu-DOTATATE are shown to have efficacy for treating PPGLs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Genetics play an important role in pediatric PPGLs. Advances in somatostatin receptor-based technology have led to use of <jats:sup>68<\/jats:sup>Ga-DOTATATE and <jats:sup>64<\/jats:sup>Cu-DOTATATE as preferred imaging modalities. While surgery remains the mainstay for management of PPGLs, PRRT is emerging as a treatment option for PPGLs<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001029","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:02:12Z","timestamp":1622073732000},"page":"430-435","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Pheochromocytomas and paragangliomas"],"prefix":"10.1097","volume":"33","author":[{"given":"Kevin","family":"Yen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Lodish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/B978-1-4557-4858-7.00023-8","article-title":"Chapter 14 \u2013 Pheochromocytoma and multiple endocrine neoplasia syndromes","author":"Waguespack","year":"2014","journal-title":"Pediatric endocrinology"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1651-2227.1992.tb12213.x","article-title":"A single pediatric center experience with 1025 children with hypertension","volume":"81","author":"Wyszy\u0144ska","year":"1992","journal-title":"Acta Paediatr"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0002-9610(00)00296-8","article-title":"Adrenal pheochromocytoma remains a frequently overlooked diagnosis","volume":"179","author":"Lo","year":"2000","journal-title":"Am J Surg"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"e2251","DOI":"10.1210\/clinem\/dgaa965","article-title":"Incidence and clinical presentation of pheochromocytoma and sympathetic paraganglioma: a population-based study","volume":"106","author":"Ebbehoj","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","article-title":"Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours","volume":"28","author":"Lam","year":"2017","journal-title":"Endocr Pathol"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"e28332","DOI":"10.1002\/pbc.28332","article-title":"Pheochromocytomas and paragangliomas in children: data from the Italian Cooperative Study (TREP)","volume":"67","author":"Virgone","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.trecan.2017.11.001","article-title":"Genomic landscape of pheochromocytoma and paraganglioma","volume":"4","author":"Jochmanova","year":"2018","journal-title":"Trends Cancer"},{"key":"R11-20250730","article-title":"Pheochromocytoma","author":"Neumann","year":"2018","journal-title":"Harrison's principles of internal medicine"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of pediatric vs adult pheochromocytomas and paragangliomas","volume":"102","author":"Pamporaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.3390\/jcm9103108","article-title":"Measurements of plasma-free metanephrines by immunoassay versus urinary metanephrines and catecholamines by liquid chromatography with amperometric detection for the diagnosis of pheochromocytoma\/paraganglioma","volume":"9","author":"Raber","year":"2020","journal-title":"J Clin Med"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12020-020-02267-8","article-title":"Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma","volume":"69","author":"Wang","year":"2020","journal-title":"Endocrine"},{"key":"R15-20250730","first-page":"69","article-title":"Metabologenomics of phaeochromocytoma and paraganglioma: an integrated approach for personalised biochemical and genetic testing","volume":"38","author":"Eisenhofer","year":"2017","journal-title":"Clin Biochem Rev"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-19-1016","article-title":"Overnight\/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?","volume":"182","author":"Peitzsch","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"122306","DOI":"10.1016\/j.jchromb.2020.122306","article-title":"Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas","volume":"1156","author":"Wang","year":"2020","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cca.2019.03.1620","article-title":"Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: particular importance for early infancy","volume":"494","author":"Peitzsch","year":"2019","journal-title":"Clin Chim Acta"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing but NET: a review of neuroendocrine tumors and carcinomas","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.eprac.2020.09.011","article-title":"Chromogranin A in a cohort of pheochromocytomas and paragangliomas: usefulness at diagnosis and as an early biomarker of recurrence","volume":"27","author":"Parisien-La Salle","year":"2021","journal-title":"Endocr Pract"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/aoms.2016.57577","article-title":"Chromogranin A \u2013 unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls","volume":"12","author":"Gut","year":"2016","journal-title":"Arch Med Sci"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00006231-200607000-00006","article-title":"Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study","volume":"27","author":"Lumachi","year":"2006","journal-title":"Nucl Med Commun"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1410619","article-title":"Pheochromocytoma in Italy: a multicentric retrospective study","volume":"141","author":"Mannelli","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1542\/peds.2005-2299","article-title":"Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center","volume":"118","author":"Pham","year":"2006","journal-title":"Pediatrics"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00259-017-3896-9","article-title":"Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)-related pheochromocytoma and paraganglioma in the pediatric population","volume":"45","author":"Jha","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40644-016-0084-2","article-title":"68Ga-DOTATATE and 18F-FDG PET\/CT in paraganglioma and pheochromocytoma: utility, patterns and heterogeneity","volume":"16","author":"Chang","year":"2016","journal-title":"Cancer Imaging"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1177\/0284185118764206","article-title":"68Ga-somatostatin receptor analogs and 18F-FDG PET\/CT in the localization of metastatic pheochromocytomas and paragangliomas with germline mutations: a meta-analysis","volume":"59","author":"Kan","year":"2018","journal-title":"Acta Radiol"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cen.13737","article-title":"Role of DOTATATE-PET\/CT in preoperative assessment of phaeochromocytoma and paragangliomas","volume":"89","author":"Gild","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Janssen","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.115.161018","article-title":"[68Ga]-DOTATATE PET\/CT in the localization of head and neck paragangliomas compared to other functional imaging modalities and CT\/MRI","volume":"57","author":"Janssen","year":"2016","journal-title":"J Nucl Med"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/jpem-2020-0354","article-title":"The utility of 68Ga-DOTATATE PET\/CT in localizing primary\/metastatic pheochromocytoma and paraganglioma in children and adolescents \u2013 a single-center experience","volume":"34","author":"Jaiswal","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2967\/jnumed.116.180430","article-title":"Head-to-head comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET\/CT: a prospective study of 59 patients with neuroendocrine tumors","volume":"58","author":"Johnbeck","year":"2017","journal-title":"J Nucl Med"},{"key":"R35-20250730","first-page":"617","article-title":"New advances in peptide receptor radionuclide therapy","volume":"43","author":"de Jong","year":"2002","journal-title":"J Nucl Med"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jso.24553","article-title":"Peptide receptor radionuclide treatment and (131)I-MIBG in the management of patients with metastatic\/progressive phaeochromocytomas and paragangliomas","volume":"115","author":"Nastos","year":"2017","journal-title":"J Surg Oncol"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2967\/jnumed.117.202903","article-title":"90Y-DOTATOC dosimetry-based personalized peptide receptor radionuclide therapy","volume":"59","author":"Menda","year":"2018","journal-title":"J Nucl Med"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2967\/jnumed.110.075101","article-title":"Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention","volume":"51","author":"Vegt","year":"2010","journal-title":"J Nucl Med"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/cancers11070909","article-title":"Favorable outcome in patients with pheochromocytoma and paraganglioma treated with 177Lu-DOTATATE","volume":"11","author":"Vyakaranam","year":"2019","journal-title":"Cancers"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1530\/EC-20-0292","article-title":"177Lu-DOTATATE therapy in metastatic\/inoperable pheochromocytoma-paraganglioma","volume":"9","author":"Jaiswal","year":"2020","journal-title":"Endocr Connect"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1245\/s10434-015-4519-y","article-title":"Hemodynamic stability during pheochromocytoma resection: lessons learned over the last two decades","volume":"22","author":"Livingstone","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R42-20250730","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1210\/clinem\/dgaa441","article-title":"Approach to the patient: perioperative management of the patient with pheochromocytoma or sympathetic paraganglioma","volume":"105","author":"Berends","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative management of the pheochromocytoma patient","volume":"92","author":"Pacak","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1507\/endocrj.EJ17-0276","article-title":"Efficacy and safety of metyrosine in pheochromocytoma\/paraganglioma: a multicenter trial in Japan","volume":"65","author":"Naruse","year":"2018","journal-title":"Endocr J"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1210\/clinem\/dgz188","article-title":"Efficacy of \u03b1-blockers on hemodynamic control during pheochromocytoma resection: a randomized controlled trial","volume":"105","author":"Buitenwerf","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0039-6060(96)80058-4","article-title":"Is laparoscopic adrenalectomy indicated for pheochromocytomas?","volume":"120","author":"Gagner","year":"1996","journal-title":"Surgery"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"e198898","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy","volume":"2","author":"Neumann","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"bvaa039","DOI":"10.1210\/jendso\/bvaa039","article-title":"Pheochromocytoma and paraganglioma in children and adolescents: experience of the French Society of Pediatric Oncology (SFCE)","volume":"4","author":"de Tersant","year":"2020","journal-title":"J Endocr Soc"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.surg.2003.08.005","article-title":"Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy","volume":"134","author":"Brauckhoff","year":"2003","journal-title":"Surgery"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:09:54Z","timestamp":1753898994000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001029","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]}}}